CELL-FREE PRODUCTION OF RHESUS BLOOD GROUP ANTIGENS

Red blood cell

Red blood cell (RBC) allo-immunization is the immune response of an individual to foreign RBC antigens not present on the surface of their own cells. An efficient detection of alloantibodies is of major interest to manage transfusions in regularly transfused patients, or for the pregnancy follow-up in the context of haemolytic disease of the foetus and new-born (HDFN). However, The Rh blood group system is one of the most polymorphic and immunogenic system, defined by least 54 Rh antigens, some of which being very rare in the population. To date, available commercial test cell reagents, composed of red cell panels expressing different Rh phenotypes, are able to encompass only few of these Rh specificities. Researchers have developed a cell-free system for the production of RH proteins, allowing to obtain large quantities of these proteins in their native state. The method, validated on RhD and RhD-RhAG antigens, relies on the use of in-house assembled nanodiscs, able to incorporate membrane proteins, preserving not only the solubility but also the conformation of newly synthetized membrane proteins. This is to date the first method allowing to generate in vitro Rh antigens with a correct conformation and, thus, ready to be tested by several antibodies, thereby representing a new approach for diagnostic in hematology laboratories investigations.

 

Applications

  • Diagnostic in hematology (cellindependent detection kit for antibody screening and identification)
  • Research tool for the cell-free production of proteins in their native conformation

 

Competitive advantages

  • Method not relying on the availability of RH group antigens in the population
  • No need to use biological material such as RBC panels
  • Production of soluble antigens in their native conformation

 

Intellectual property

International patent application in 2017 (WO/2017/064294A1)
Patent delivered in EP, US, CN and CA

 

Keywords

Red-Blood-cell antigens - Rhesus phenotypes - Blood transfusion - Cell-free antigen production - Protein conformation

Télécharger la fiche de technologie

Tout s’accélère.
Et vous ?

Erganeo se tient à votre écoute.

votre sujet
Pour toute information concernant les données personnelles, consultez les mentions légales.